Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus

被引：11

作者：

Ginzler, EM ^{[1
]}

Aranow, C ^{[1
]}

机构：

[1] SUNY Hlth Sci Ctr, Div Rheumatol, Brooklyn, NY 11203 USA

来源：

BAILLIERES CLINICAL RHEUMATOLOGY | 1998年 / 12卷 / 03期

关键词：

corticosteroids; steroid toxicity; infection; osteoporosis; avascular necrosis; peptic ulcer disease;

D O I：

10.1016/S0950-3579(98)80032-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Corticosteroid therapy has had a major impact on improvement in disease activity and long-term survival in patients with systemic lupus erythematosus (SLE). Unfortunately, the therapeutic advantages are accompanied by many manifestations of toxicity, some of which are short term and potentially reversible, while others cause chronic irreversible damage. Many of these features of toxicity have similar presentations to manifestations of SLE disease activity, and must be distinguished in the individual patient. The features of corticosteroid toxicity are reviewed in this chapter, and means of prevention and/or treatment are discussed.

引用

页码：495 / 510

页数：16

共 50 条

[21] Treatment of systemic lupus erythematosus
Ochsendorf, FR
Runne, U
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (27) : 877 - 877
[22] Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus
Kaieda, Shinjiro
Kobayashi, Teppei
Moroki, Mariko
Honda, Seiyo
Yuge, Kentaro
Kawano, Hiroshi
Mitsuyama, Keiichi
Sata, Michio
Ida, Hiroaki
Hoshino, Tomoaki
Fukuda, Takaaki
MODERN RHEUMATOLOGY, 2014, 24 (02) : 357 - 360
[23] Corticosteroids and immunosupressors as the only treatment of bullous systemic lupus erythematosus: Report of four cases
Fernandez-Sanchez, Monica
Garcia-Hidalgo, Linda
Saeb, Marcela
Orozco-Topete, Rocio
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB65 - AB65
[24] ADVERSE EVENTS AND THE RELAPSE RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS DURING HYDROXYCHLOROQUINE TREATMENT
Ichinose, Kunihiro
Fujikawa, Keita
Mizokami, Akinari
Aramaki, Toshiyuki
Ueki, Yukitaka
Eguchi, Mizuna
Okamoto, Momoko
Endo, Yushiro
Tsuji, Sousuke
Takatani, Ayuko
Shimizu, Toshimasa
Sumiyoshi, Remi
Koga, Tomohiro
Kawashiri, Shin-Ya
Iwamoto, Naoki
Igawa, Takashi
Tamai, Mami
Nakamura, Hideki
Origuchi, Tomoki
Kawakami, Atsushi
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1697 - 1697
[25] Ophthalmologic adverse effects of systemic corticosteroids
Lebreton, O.
Weber, M.
REVUE DE MEDECINE INTERNE, 2011, 32 (08): : 506 - 512
[26] PREVENTION OF RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
BOOTSMA, H
SPRONK, P
DERKSEN, R
DEBOER, G
WOLTERSDICKE, H
HERMANS, J
LIMBURG, P
GMELIGMEYLING, F
KATER, L
KALLENBERG, C
LANCET, 1995, 345 (8965): : 1595 - 1599
[27] Lupus enteritis: An uncommon manifestation of systemic lupus erythematosus with favourable outcome on corticosteroids
Thomas, G.
Ebbo, M.
Genot, S.
Bernit, E.
Mazodier, K.
Veit, V.
Lagrange, X.
Heyries, L.
Kaplanski, G.
Schleinitz, N.
Harle, J. -R.
REVUE DE MEDECINE INTERNE, 2010, 31 (07): : 493 - 497
[28] CORTICOSTEROIDS AND NEUROPSYCHOLOGICAL FUNCTIONING IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
DENBURG, SD
CARBOTTE, RM
DENBURG, JA
ARTHRITIS AND RHEUMATISM, 1994, 37 (09): : 1311 - 1320
[29] BURDEN OF DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS TREATED WITH CORTICOSTEROIDS
Strand, V.
Johnson, J.
Vandeloo, C.
Galateanu, C.
Lobosco, S.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1171 - 1171
[30] Dietary Energy Intake and Corticosteroids in Children with Systemic Lupus Erythematosus
Tyrrell, Pascal N.
Manuel, Lisa C.
McCrindle, Brian W.
Silverman, Earl D.
JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2612 - 2612

← 1 2 3 4 5 →